Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Certara Inc (CERT)

Certara Inc (CERT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,679,611
  • Shares Outstanding, K 160,841
  • Annual Sales, $ 354,340 K
  • Annual Income, $ -55,360 K
  • 60-Month Beta 1.61
  • Price/Sales 7.59
  • Price/Cash Flow 17.68
  • Price/Book 2.54
Trade CERT with:

Options Overview Details

View History
  • Implied Volatility 104.65% ( -8.12%)
  • Historical Volatility 39.53%
  • IV Percentile 96%
  • IV Rank 89.89%
  • IV High 116.38% on 09/27/23
  • IV Low 0.40% on 10/26/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 5
  • Volume Avg (30-Day) 20
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 554
  • Open Int (30-Day) 736

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.07
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate 0.06
  • Prior Year 0.10
  • Growth Rate Est. (year over year) -30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.64 +5.43%
on 05/16/24
17.94 -8.08%
on 05/03/24
-0.59 (-3.45%)
since 04/29/24
3-Month
15.64 +5.43%
on 05/16/24
19.87 -17.01%
on 03/08/24
-0.39 (-2.31%)
since 02/29/24
52-Week
11.81 +39.63%
on 11/01/23
22.65 -27.20%
on 06/07/23
-4.73 (-22.29%)
since 05/26/23

Most Recent Stories

More News
Certara, Inc. (CERT) Matches Q1 Earnings Estimates

Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

CERT : 16.49 (-1.02%)
MGTX : 5.00 (-2.72%)
Guardant Health (GH) Expected to Beat Earnings Estimates: Should You Buy?

Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GH : 26.09 (-0.27%)
CERT : 16.49 (-1.02%)
Repligen (RGEN) Surpasses Q1 Earnings and Revenue Estimates

Repligen (RGEN) delivered earnings and revenue surprises of 8.47% and 0.91%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

RGEN : 152.06 (-2.99%)
CERT : 16.49 (-1.02%)
Factors to Note Ahead of Atlassian's (TEAM) Q3 Earnings Release

Atlassian's (TEAM) Q3 results are likely to reflect the benefits of increased demand for its solutions amid accelerated digital transformations and cloud adoptions.

GRMN : 161.66 (-0.46%)
PYPL : 61.05 (-1.80%)
TEAM : 165.76 (+0.57%)
CERT : 16.49 (-1.02%)
DraftKings (DKNG) to Report Q1 Earnings: What's in Store?

DraftKings' (DKNG) first-quarter 2023 performance is likely to have benefited from the robust demand for mobile sports betting and expansion efforts in new states.

PODD : 172.25 (-3.13%)
DKNG : 35.96 (-1.78%)
CERT : 16.49 (-1.02%)
BITF : 2.18 (-1.36%)
Certara, Inc. (CERT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERT : 16.49 (-1.02%)
CTMX : 1.7500 (-2.23%)
The Zacks Analyst Blog Highlights Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara

Shake Shack, Wingstop, AssetMark Financial, Primerica and Certara are included in this Analyst Blog.

PRI : 222.01 (-0.38%)
SHAK : 95.03 (-0.88%)
WING : 387.02 (-0.66%)
AMK : 34.10 (-0.03%)
CERT : 16.49 (-1.02%)
Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data

Creative Medical Technology (CELZ) reports positive one-year follow-up data from a study showing the efficacy of CELZ-001 in treating type II diabetes without any serious adverse effects.

CRSP : 53.85 (-1.81%)
CERT : 16.49 (-1.02%)
CELZ : 4.35 (-1.14%)
EQRX : 2.34 (-2.09%)
Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab Setback

Moderna (MRNA) expects $8-$15 billion in product revenues from the respiratory vaccine by 2027. Its first influenza vaccine candidate failed to meet the statistical threshold for early success.

MRNA : 147.92 (-3.45%)
CRSP : 53.85 (-1.81%)
CERT : 16.49 (-1.02%)
EQRX : 2.34 (-2.09%)
Moderna (MRNA), Merck's Cancer Jab Gets EMA's PRIME Tag

The EMA grants PRIME designation to Moderna's (MRNA) personalized cancer vaccine candidate combined with Merck's Keytruda for treating certain types of melanoma.

MRK : 125.90 (-0.15%)
MRNA : 147.92 (-3.45%)
CRSP : 53.85 (-1.81%)
CERT : 16.49 (-1.02%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Certara Inc. provides medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Certara Inc. is based in NJ, United States.

See More

Key Turning Points

3rd Resistance Point 17.16
2nd Resistance Point 16.96
1st Resistance Point 16.72
Last Price 16.49
1st Support Level 16.28
2nd Support Level 16.08
3rd Support Level 15.84

See More

52-Week High 22.65
Fibonacci 61.8% 18.51
Fibonacci 50% 17.23
Last Price 16.49
Fibonacci 38.2% 15.95
52-Week Low 11.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar